<DOC>
	<DOCNO>NCT02624934</DOCNO>
	<brief_summary>Aortic stenosis major cause morbidity around world . Progressive aortic stenosis lead cardiac hypertrophy compensatory response . A maladaptive response may lead heart failure vary degree severity aortic stenosis individual patient . The predict factor occurrence maladaptive response well define . Therefore current medical therapy aortic stenosis consider insufficient may actually cause harm . The effective therapy severe , symptomatic aortic stenosis aortic valve replacement . It find experimental study Podocan determines degree cardiac hypertrophy response pressure overload via Wnt-pathway . The possible prognostic role secrete circulate Wnt modulators aortic stenosis also recently gain attention . This project attempt establish prognostic role circulatory Podocan Wnt modulators maladaptive leave ventricular response aortic stenosis . This may help identify patient particular risk develop leave ventricular dysfunction aortic stenosis improve understand mechanism leave ventricular remodel aortic stenosis . Hence , may also later act important background find effective therapy prevent delay maladaptive leave ventricular response aortic stenosis .</brief_summary>
	<brief_title>Podocan Wnt Pathway Left Ventricular Remodeling Aortic Stenosis</brief_title>
	<detailed_description>Valvular heart disease common clinical indication ass patient cardiac MRI . Cardiac MRI comprehensive study use multiple image sequences.Cardiac MRI indicate image native prosthetic aortic valve . Planimetry aortic valve valuable determination severity aortic stenosis . Cardiac MRI accurate reproducible image modality ass leave ventricular function mass . Left ventricular ( LV ) function primary determinant outcome follow aortic valve replacement . LV mass increase severe aortic stenosis . Variations morphology hypertrophy response aortic stenosis detect cardiac MRI . Cardiac MRI commonly use assess aortic stenosis context discordant information alternative imaging modality low gradient aortic stenosis . It expect 100 participant enrol study 24 month . This sample size agree upon discussion statistic team . Patients agree participate provide inform consent prior cardiac MRI . A 6 minute walk test measure baseline functional status do consent , preferably prior report MRI suite schedule test . Standard cardiac MRI obtain . All patient cardiac MRI IV line place normal procedure . When line place , prior contrast infusion ( applicable ) medication administration , blood sample collect test circulatory Podocan Wnt pathway molecule . Approximately 20 cc draw total . All specimens sent experimental lab Dr. Paul Klotman Baylor Medical Center . All Podocan &amp; Wnt pathway effectory molecule assays complete Dr. Klotman 's lab . The following measurement collect cardiac MRI : LV end diastolic ( ED ) volume : ml LV ED index : ml/m2 LV end systolic ( ES ) volume : ml LV ES index : ml/m2 LV ejection fraction ( EF ) : % LV Stroke Volume : ml LV Stroke Index : ml/m2 LV Cardiac Output : L/min LV Cardiac Index : L/min/M2 LV Mass : g LV Mass index : g/m2 At 12 month post procedure follow information collect participant ' chart endpoint analysis : All cause mortality Cardiac mortality Hospital admission valvular disease related clinical event congestive heart failure , angina , syncope Valve replacement surgery Patients undergo valve replacement surgery 12 month follow period schedule undergo post-op follow cardiac MRI ( expect 9-12 month post-op ) ask provide additional blood sample test circulatory Podocan Wnt pathway molecule time MRI . Each participant 's chart review time enrollment follow variable abstract medical record : age , gender , ethnicity , Most recent Ht , Wt , BP , Heart Rate BMI Tobacco use/history Alcohol use/ history Comorbidities - Hypertension - Hyperlipidemia - Diabetes - Chronic Kidney Disease - Cancer - CAD Info previous echocardiogram : - Ejection fraction - Valve area - Gradient Info previous cardiac cath ( do ) : - Presence/absence coronary stenosis - Location &amp; degree stenosis - Aortic valve area - Calculation valve area Info previous ECG : - Rhythm - Left Ventricular Hypertrophy Medications Laboratory data : - Lipids - Chemistries - Complete Blood Count - Hemoglobin A1C - Troponin - B-type Natriuretic Peptide</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Ventricular Remodeling</mesh_term>
	<criteria>Age 18 great Scheduled Cardiac MRI Patients know aortic valve area le 1 cmÂ² echocardiogram Able provide inform consent Ambulatory expect able complete 6 minute walk test Other significant ( moderate severe ) valvular heart disease Unable complete 6 minute walk test ( ex . Wheelchair bound )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>